Clinical Research Directory
Browse clinical research sites, groups, and studies.
Biomarkers to Predict and Monitor Response to Infliximab
Sponsor: Massachusetts General Hospital
Summary
The aim of the study is to generate novel minimally-invasive serum protein signatures and biomarkers in children and adolescents with Crohn's Disease (CD) that correlate with and can predict and monitor patients who will have a prolonged response to Infliximab so that personalized medicine can be applied to patients with CD.
Official title: Detection of Serum Protein Biomarkers to Predict and Monitor Response to Infliximab Using SOMAscan
Key Details
Gender
All
Age Range
3 Years - 20 Years
Study Type
OBSERVATIONAL
Enrollment
107
Start Date
2019-11-18
Completion Date
2024-11-01
Last Updated
2026-10-28
Healthy Volunteers
Not specified
Conditions
Interventions
Infliximab
Blood collection
Locations (1)
MassGeneral for Children
Boston, Massachusetts, United States